PAPER Roney M, Uddin MN, Khan AA, Fatima S, Mohd Aluwi MF, Hamim SM, Ahmad A

Repurposing of dipeptidyl peptidase FDA-approved drugs in Alzheimer's disease using network pharmacology and in-silico approaches.

Comput Biol Chem. 2025 Jun;116:108378. Epub 2025 Feb 8 PubMed.

PAPER Rocha FM, Roy A, Varshney M, Kumar A

Mapping reactive astrogliosis in Parkinson's brain with astroglial tracers BU99008 and Deprenyl: New insights from a multi-marker postmortem study.

Alzheimers Dement. 2025 Feb 12;:e14488. Epub 2025 Feb 12 PubMed.

PAPER Wu J, Sun H, Zhao Y, Lian L, Bian H, Guo Y, Li D, Huang L

The spectrum-efficacy correlation of Kai-Xin-San for cognition of Aβ42 transgenic Drosophila and verification of its active ingredients.

Front Pharmacol. 2025;16:1538837. Epub 2025 Jan 28 PubMed.

PAPER Leisgang Osse AM, Kinney JW, Cummings JL

The Common Alzheimer's Disease Research Ontology (CADRO) for biomarker categorization.

Alzheimers Dement (N Y). 2025;11(1):e70050. Epub 2025 Feb 11 PubMed.

PAPER Andersson E, Lindblom N, Janelidze S, Salvadó G, Gkanatsiou E, Söderberg L, Möller C, Lannfelt L, Ge J, Hanrieder J, Blennow K, Deierborg T, Mattsson-Carlgren N, Zetterberg H, Gouras G, Hansson O

Soluble cerebral Aβ protofibrils link Aβ plaque pathology to changes in CSF Aβ42/Aβ40 ratios, neurofilament light and tau in Alzheimer's disease model mice.

Nat Aging. 2025 Feb 12; Epub 2025 Feb 12 PubMed.

PAPER Fandler-Höfler S, Kaushik K, Storti B, Pikija S, Mallon D, Ambler G, Damavandi PT, Panteleienko L, Canavero I, van Walderveen MA, van Etten ES, DiFrancesco JC, Enzinger C, Gattringer T, Bersano A, Wermer MJ, Banerjee G, Werring DJ

Clinical-radiological presentation and natural history of iatrogenic cerebral amyloid angiopathy.

J Neurol Neurosurg Psychiatry. 2025 Feb 12; Epub 2025 Feb 12 PubMed.

PAPER Copeland EN, LeBlanc PJ, Duarte-Guterman P, Fajardo VA, MacPherson RE

The link between sarcopenic obesity and Alzheimer's disease: a brain-derived neurotrophic factor point of view.

J Physiol. 2025 Feb 12; Epub 2025 Feb 12 PubMed.

PAPER Grassano M, Chiò A

microRNA in ALS: finally ready for prime time?

Neurol Sci. 2025 Feb 12; Epub 2025 Feb 12 PubMed.

PAPER Tsuruta M, Shil S, Taniguchi S, Kawauchi K, Miyoshi D

The role of cytosine methylation in regulating the topology and liquid-liquid phase separation of DNA G-quadruplexes.

Chem Sci. 2025 Jan 31; Epub 2025 Jan 31 PubMed.

Kewei Zhu

PAPER Nguyen L, Ajredini R, Guo S, Romano LE, Tomas RF, Bell LR, Ranum PT, Zu T, Bañez Coronel M, Kelley CP, Redding-Ochoa J, Nizamis E, Melloni A, Connors TR, Gaona A, Thangaraju K, Pletnikova O, Clark HB, Davidson BL, Yachnis AT, Golde TE, Lou X, Wang ET, Renton AE, Goate A, Valdmanis PN, Prokop S, Troncoso JC, Hyman BT, Ranum LP

CASP8 intronic expansion identified by poly-glycine-arginine pathology increases Alzheimer's disease risk.

Proc Natl Acad Sci U S A. 2025 Feb 18;122(7):e2416885122. Epub 2025 Feb 12 PubMed.

PAPER Zúñiga CH, Acosta BI, Menchaca R, Amescua CA, Hong S, Hui L, Gil M, Rhee YH, Yoon S, Kim M, Chang PY, Kim YM, Song PY, Betito K

Treatment of Alzheimer's Disease subjects with expanded non-genetically modified autologous natural killer cells (SNK01): a phase I study.

Alzheimers Res Ther. 2025 Feb 12;17(1):40. PubMed.

PAPER Kuriyama M, Wang CF, Nagase T, Sohma Y, Kanai M, Hori Y, Tomita T

Proteolytic therapeutic modalities for amyloidoses: Insights into immunotherapy, PROTAC, and photo-oxygenation.

Neurotherapeutics. 2025 Feb 11;:e00548. Epub 2025 Feb 11 PubMed.

PAPER Dimoula K, Papagiannakis N, Maniati M, Stefanis L, Emmanouilidou E

Aggregated α-synuclein in erythrocytes as a potential biomarker for idiopathic Parkinson's Disease.

Parkinsonism Relat Disord. 2025 Feb 6;133:107321. Epub 2025 Feb 6 PubMed.

PAPER Qin F, Cao R, Cui W, Bai X, Yuan J, Zhang Y, Liu Y, Cao N, Dong N, Zhou M, Chen T, Liu F, Sun W, Zheng Y, Zhao W, Liu B, Gao C

Listerin promotes α-synuclein degradation to alleviate Parkinson's disease through the ESCRT pathway.

Sci Adv. 2025 Feb 14;11(7):eadp3672. Epub 2025 Feb 12 PubMed.